✦ LIBER ✦

Efficacy and tolerability of OROS hydromorphone extended release in patients with moderate to severe osteoarthritis pain: a phase 3, flexible-dose, randomized, double-blind, placebo-controlled study

✍ Scribed by M. Hale; J. Patrick; S. Nalamachu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind study of OROS

✍ D. Taylor; M. Kutch 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 38 KB

A randomized, double-blind study of OROS

✍ M. Hale; R. Rauck; S. Li; M. Kutch 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Results of a Double-blind, Placebo-contr

✍ Richard Rauck; Ronald Rapoport; John Thipphawong 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB

375 EFFICACY AND SAFETY OF TWICE-DAILY D

✍ L. Gilderman; J. Box; B. Rankin; G. Podolsky; D. Morris; J. Thomas; E. Lockhart; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Oxymorphone Extended-Release Tablets Rel

✍ Alan K. Matsumoto; Najib Babul; Harry Ahdieh 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Poster 48: Gastrointestinal Tolerability

✍ Douglas Shapiro; Robert Buynak; Mila S. Etropolski; Claudia Lange; Akiko Okamoto 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 52 KB